PRF1 and cancer: Furthermore, multi-immunofluorescence staining (Fig. 6e) analysis indicated that compared with monotherapy or parental groups, the combination therapy remarkably increased CD8+ T cell infiltration and perforin in MUS81 knockdown cancer cells (Fig. 6f).